Jean-Yves Blay

Directeur/Membre du Conseil chez INNATE PHARMA

Fortune : 137 $ au 31/05/2024

61 ans

Health Technology

Consumer Services

Commercial Services

Postes actifs de Jean-Yves Blay

Sociétés	Poste	Début	Fin
INNATE PHARMA	Directeur/Membre du Conseil	13/12/2017	-
INNATE PHARMA	Independent Dir/Board Member	13/12/2017	-
TRANSGENE	Directeur/Membre du Conseil	25/05/2022	-
TRANSGENE	Independent Dir/Board Member	25/05/2022	-
Centre Léon Bérard Lyon et Rhône-Alpes	Directeur Général	01/01/2014	-

Sociétés	Poste	Début	Fin
UNICANCER UNICANCER Hospital/Nursing ManagementHealth Services UNICANCER is a French hospital network that is dedicated to fighting against cancer. The private company is based in Paris, France. It is the only national hospital federation that is solely focused on oncology. The network comprises of 18 French cancer centers (CLCC) and a private non-profit health establishment. The CLCCs take care of almost 530,000 patients annually. UNICANCER is also a leading academic promoter of clinical trials in oncology in Europe, with 106 active clinical trials promoted and nearly 7,600 patients included.	President	01/01/2019	01/01/2022
European Organisation for Research & Treatment of Cancer	President	01/01/2009	01/01/2012
Académie Nationale de Médecine FCP	Corporate Officer/Principal	01/01/2016	-

Université Claude Bernard Lyon 1

Doctorate Degree

Internationale

France	7
Belgique	2

Opérationnelle

Director/Board Member	2
Independent Dir/Board Member	2
President	2

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
TRANSGENE	Health Technology
INNATE PHARMA	Health Technology

Entreprise privées	4
European Organisation for Research & Treatment of Cancer
Académie Nationale de Médecine FCP	Commercial Services
UNICANCER UNICANCER Hospital/Nursing ManagementHealth Services UNICANCER is a French hospital network that is dedicated to fighting against cancer. The private company is based in Paris, France. It is the only national hospital federation that is solely focused on oncology. The network comprises of 18 French cancer centers (CLCC) and a private non-profit health establishment. The CLCCs take care of almost 530,000 patients annually. UNICANCER is also a leading academic promoter of clinical trials in oncology in Europe, with 106 active clinical trials promoted and nearly 7,600 patients included.	Health Services
Centre Léon Bérard Lyon et Rhône-Alpes